Home > Learning Modules > Current Controversies in Antiretroviral Therapy
Current Controversies in Antiretroviral Therapy
Sorry, this learning module is not available for mobile devices.
-
Roy Gulick, MD, MPH
Professor of Medicine and Chief of the Division of Infectious Diseases
Weill Medical College of Cornell University in New York City
Presentation Date: 3/15/2011
Release Date: 3/15/2011
Learning Objectives
- Be aware of newer antiretroviral agents.
- Discuss the latest data on strategies for starting antiretroviral therapy and what to start with.
- Discuss the latest data on when to change antiretroviral therapy and what to change to.
Presenter Bio
Dr. Gulick is Professor of Medicine and Chief of the Division of Infectious Diseases at Weill Medical College of Cornell University in New York City. He currently serves as Principal Investigator of the Cornell HIV Clinical Trials Unit of the AIDS Clinical Trials Group (ACTG), sponsored by the National Institutes of Health. He also serves as a Board Member of the International AIDS Society-USA, and as a member of the Panel on Clinical Practices for Treatment of HIV Infection of the U.S. Department of Health and Human Services.
PRN Learning Modules
